~~<i id='A4D2DCE03E'><strike id='A4D2DCE03E'><tt id='A4D2DCE03E'><pre id='A4D2DCE03E'></pre></tt></strike></i>~~

Home» explore» focus

focus

author：entertainment 2025-09-28 11:21:58 Page View：8

Editor’s note: A recording of the event is embedded below.

After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.

Featured Speakers

Irena Melnikova, Ph.D., partner, Pfizer Ventures
Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer stories no one wants to hear
Next article： At least 13 dead in Texas as scorching temps continue

focus

In Memoriam: Notable people who died in 2023

1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

H.R. 3 is the wrong path to lower drug costs

Fromleft,Rep.RichardNeal(D-Mass.)speaksasRep.FrankPallone(D-N.J.)andHouseSpeakerNancyPelosi(D-Calif.

At least 13 dead in Texas as scorching temps continue

1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

Study: New antibiotic targets gonorrhea as well as last existing drug

ColorizedscanningelectronmicrographofNeisseriagonorrhoeaebacteria,whichcausesgonorrhea.NIAIDAnimport

WSS

focus

focus

Featured Speakers

leisure time

focus

Study: New antibiotic targets gonorrhea as well as last existing drug